155 related articles for article (PubMed ID: 38292656)
1. Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma.
Li Y; Lee W; Zhao ZG; Liu Y; Cui H; Wang HY
World J Clin Oncol; 2024 Jan; 15(1):130-144. PubMed ID: 38292656
[TBL] [Abstract][Full Text] [Related]
2. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
Farrell M; Fairfield H; Karam M; D'Amico A; Murphy CS; Falank C; Pistofidi RS; Cao A; Marinac CR; Dragon JA; McGuinness L; Gartner CG; Iorio RD; Jachimowicz E; DeMambro V; Vary C; Reagan MR
Elife; 2023 Mar; 12():. PubMed ID: 36880649
[TBL] [Abstract][Full Text] [Related]
3. [Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma].
Lin YX; Chen K; An FM; Wang YF; Wu XB; Zhan Q; Zhang GQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1006-1013. PubMed ID: 34814397
[No Abstract] [Full Text] [Related]
4. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
5. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma.
Li Y; Zhao ZG; Luo Y; Cui H; Wang HY; Jia YF; Gao YT
World J Gastroenterol; 2020 Aug; 26(32):4786-4801. PubMed ID: 32921957
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
[TBL] [Abstract][Full Text] [Related]
7. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic role and potential regulatory mechanism of fatty acid binding protein 5 based on a pan-cancer analysis.
Wang J; Zhao S; Sun J; Wang X; Guan M; Yin J; Tang B
Sci Rep; 2023 Mar; 13(1):4060. PubMed ID: 36906605
[TBL] [Abstract][Full Text] [Related]
9. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH
Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
[TBL] [Abstract][Full Text] [Related]
11. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose.
Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J
Islets; 2010; 2(3):174-84. PubMed ID: 21099311
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of fatty acid-binding proteins and pathological implications in the progression of tongue carcinoma.
Ohyama Y; Kawamoto Y; Chiba T; Kikuchi K; Sakashita H; Imai K
Mol Clin Oncol; 2014 Jan; 2(1):19-25. PubMed ID: 24649302
[TBL] [Abstract][Full Text] [Related]
13. Serum fatty acid-binding protein 5 is a significant factor in hepatocellular carcinoma progression independent of tissue expression level.
Ohira M; Yokoo H; Ogawa K; Fukai M; Kamiyama T; Sakamoto N; Taketomi A
Carcinogenesis; 2021 Jun; 42(6):794-803. PubMed ID: 33754641
[TBL] [Abstract][Full Text] [Related]
14. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
16. FABP5 as a novel molecular target in prostate cancer.
O'Sullivan SE; Kaczocha M
Drug Discov Today; 2020 Sep; ():. PubMed ID: 32966866
[TBL] [Abstract][Full Text] [Related]
17. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation-mediated NF-κB/fatty acid-binding protein 5 (FABP5) feed-forward loop promotes malignancy of colorectal cancer cells.
Kawaguchi K; Ohashi T; Kobayashi N; Kanemoto K; Nose M; Shinozaki R; Kataoka T; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159362. PubMed ID: 37414211
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.
Tang Y; Li K; Hu B; Cai Z; Li J; Tao H; Cao J
Cancer Biol Ther; 2022 Dec; 23(1):424-438. PubMed ID: 35816613
[TBL] [Abstract][Full Text] [Related]
20. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]